FRAX™: A new instrument for calculating 10-year absolute fracture risk;FRAX™: Un nuevo instrumento para calcular el riesgo absoluto de fracturas a 10 años

Medicina

Volumn 69, Issue 5, 2009, Pages 571-575

  Claus Hermberg, Haraldo ^a   Bagur, Alicia ^b   Messina, Osvaldo D ^c   Negri, Armando L ^d   Schurman, Leon ^e   Sanchez, Ariel ^f  

^a HOSPITAL ALEMÁN   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d Instituto de Investigaciones Metabolicas   (Argentina)

^e UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^f Expresidente de la Asociación Argentina de Osteología y Metabolismo Mineral   (Argentina)

Author keywords

Absolute risk; Fracture risk; FRAX; Osteoporosis; Relative risk

Indexed keywords

CLINICAL ASSESSMENT TOOL; FRACTURE RISK ASSESSMENT TOOL; HIP FRACTURE; HUMAN; MEDICAL DECISION MAKING; REVIEW; RISK FACTOR; ARTICLE; BONE DENSITY; FEMALE; FRACTURE; MALE; METHODOLOGY; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; PREDICTION AND FORECASTING; RISK ASSESSMENT;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; FEMALE; FRACTURES, BONE; HUMANS; MALE; OSTEOPOROSIS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT;

EID: 72249085184     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-1141
2. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on postmenopausal osteoporosis in women. European Agency for the Evaluation of Medicinal Products. London (CPMP/EWP/552/95 rev 1), 2001.
3. Food and Drug Administration. Clinical guidance for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Division of Metabolism and Endocrine Drug Products, Rockville (MD), 1994.
4. Royal College of Physicians. Clinical guidance for strategies to prevent and treat osteoporosis. London: Royal College of Physicians; 1999.
5. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D, on behalf of the European Foundation of Osteoporosis and Bone Disease. Guidance for diagnosis and management of osteoporosis. Osteoporos Int 1997; 7: 390-406.
6. National Osteoporosis Foundation (NOF). Physicians' guide to prevention and treatment of osteoporosis. Washington (DC): NOF, 2003.
7. Marshall D, Johnell O, Wedel JJ. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 1996; 312: 1254-1259 (Pubitemid 26147662)
8. Johnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005; 20: 1185-1194 (Pubitemid 40863806)
9. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002; 359: 1929-1936
10. Schmit SCE, van der Klift M, Weel AEAM, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 2004; 34: 195-202. (Pubitemid 38142449)
11. Wilkin T, Devendra D, Dequeker J, Luyten F. For and against. Bone densitometry is not a good predictor of hip fracture. Br Med J 2001; 323: 795-799
12. van Staa TP, Geusens P, Kanis JA, Leufkens HGM, Gehlbach S, CooperC. A simple clinical score for estimating the long-term risk of fracture in postmenopausal women. Quart J Med 2006; 99: 673-682 (Pubitemid 44542316)
13. Kaptoge S, Armbrecht G, Felsenberg D, et al. Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int 2006; 17: 1369-1381
14. Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001; 12: 19-28.
15. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and other osteoporotic fractures in men and women. Osteoporos Int 2007; 18: 1033-1046 (Pubitemid 47020000)
16. Melton III LJ, Crowson CS, O'Fallon WM, Wahner HW, Riggs BL. Relative contributions of bone density, bone turnover and clinical risk factors to long-term fracture prediction. J Bone Miner Res 2003; 18: 312-318
17. Kanis JA, Black D, Cooper C, et al., on behalf of the International Osteoporosis Foundation and the National Osteoporosis Foundation, USA. A new approach to the development of Assessment Guidelines for Osteoporosis. Osteoporos Int 2002; 13: 527-536
18. Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A. Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 2002; 30: 251-258 (Pubitemid 34044325)
19. De Laet C, Oden A, Johansson H, Johnell O, Jonsson B, Kanis JA. The impact of the use of multiple risk indicators for fracture on case-finding strategies. A mathematical approach. Osteoporos Int 2005; 16: 313-318
20. Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV. Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int 2007; 18: 1109-1117 (Pubitemid 47020008)
21. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19: 385-397
22. Kanis JA, Johansson H, Oden A, et al. A family history of fracture and fracture risk. Bone 2004; 35: 1029-1037
23. Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004; 19: 893-899 (Pubitemid 41103445)
24. Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004; 35: 375-382 (Pubitemid 38953182)
25. De Laet C, Kanis JA, Oden A, et al. Body mass index as a prediction of fracture risk. A meta-analysis. Osteoporos Int 2005; 16: 1330-1338
26. Kanis JA, Johansson H, Johnell O, et al. Alcohol intake as a risk factor for fracture. Osteoporos Int 2005; 16: 737-742 (Pubitemid 40933589)
27. Kanis JA, Johansson H, Oden A, et al. A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int 2005; 16: 799-804. (Pubitemid 40933596)
28. Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk FRAX™ WHO Fracture Risk Assessment Tool. En: a meta-analysis. Osteoporos Int 2005; 16: 222-228
29. FRAX™ WHO Fracture Risk Assessment Tool. En: http://www.shef.ac.uk/ FRAX/index.htm.; consultado dic 10, 2008.
30. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D, on behalf of the European Foundation of Osteoporosis and Bone Disease. Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 1997; 7: 390-406.
31. Kanis JA, Johnell O, Oden A, et al. Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 2000; 11: 669-674 (Pubitemid 30786246)
32. Jonsson B, Kanis JA, Dawson A, Oden A, Johnell O. Effect and offset of effect of treatments for hip fracture on health outcomes. Osteoporos Int 1999; 10: 193-199 (Pubitemid 29458713)
33. Borgström F, Johnell O, Kanis JA, Jonsson B, Rehnberg C. At what hip fracture risk is it cost-effective to treat?: International intervention thresholds for the treatment of osteoporosis. Osteoporos Int 2006; 17: 1459-1471
34. Tosteson A, Melton III LJ, Dawson-Hughes B, et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 2008; 19: 437-447
35. Dawson-Hughes B, Tosteson A, Melton III LJ, et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 2008; 19: 449-458
36. National Osteoporosis Foundation. En: http://www.nof.org/professionals/ cliniciansguide-form.asp. Consultado: 28/11/2008.
37. Effors L, Allander A, Kanis JA, et al. The variable incidence of hip fracture in Southern Europe. The MEDOS study. Osteoporos Int 1994; 4: 253-263
38. Mosquera MT, Maurel DL, Pavón S, Arregui A, Moreno C, Vázquez J. Incidencia y factores de riesgo de la frac tura de fémur proximal por osteoporosis. Panam J Public Health 1998; 3: 211-218 (Pubitemid 28267611)
39. Bagur A, Mautalen C, Rubin Z. Epidemiology of hip fractures in an urban population of central Argentina. Osteoporos Int 1994; 4: 332-335
40. Morosano M, Masoni A, Sánchez A. Incidence of hip fractures in the city of Rosario, Argentina. Osteoporos Int 2005; 16: 1339-1344 (Pubitemid 41532086)
41. Somma LF, Rosso GZ, Trobo RI, Barreira JC, Messina OD. Epidemiología de la fractura de fémur en Luján, Argentina (resumen). Osteology 2000; 3: 267.
42. Wittich A, Bagur A, Oliveri B, et al. Epidemiología de las fracturas de cadera en la provincia de Tucumán. Comunicación a la XX Reunión Anual de la Asociación Argentina de Osteología y Metabolismo Mineral. Mendoza, 2003.
43. Claus-Hermberg H, Lozano Bullrich MP, Ilera V, Malter Terrada J, Pozzo MJ. Incidencia de fracturas en mujeres afiliadas al plan médico del Hospital Alemán. Actual Osteol 2008; 4: 57-62.
44. Melton LJ, Crowson CS, O'Fallon WM. Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 1999; 9: 29-37.
45. Kanis JA, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A. The burden of osteporotic fractures: a method for setting international thresholds. Osteoporos Int 2001; 12: 417-427 (Pubitemid 32606468)
46. Singer BR, Mc Lauchlan CJ, Robinson CM, Christie J. Epidemiology of fracture in 15,000 adults: the influence of age and gender. J Bone Joint Surg Br 1998; 80: 234-238 (Pubitemid 128472087)
47. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: result from the Fracture Intervention Trial. JAMA 1998; 280: 2077-2082
48. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program study group. N Engl J Med 2001; 344: 333-340
49. Sánchez A, Salica D. Diagnóstico de osteoporosis basado en DXA: ¿Qué datos normativos deberían usarse? Rev Arg Osteología 2007; 6(2): 14-18
50. Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998; 8: 468-486
51. Ott SM. Osteoporosis in men (letter). N Engl J Med 2008; 359: 868.